A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/16/2006	WO2005117882A3 Hydroxamic acid derivatives as metalloprotease inhibitors
11/16/2006	WO2005115389A3 Specific ppar agonists for treating negative energy balance
11/16/2006	WO2005115369A3 Use of ppar agonists to treat ruminants
11/16/2006	WO2005112740A3 Noninvasive glucose sensor
11/16/2006	WO2005103047A8 Derivatives of 14.15-dihydro 20.21-dinoreburnamenin-14-ol, and applications thereof
11/16/2006	WO2005089803A3 Pharmaceutical compositions for the treatment of skin diseases comprising a combination of epinastine and one or more additional minerals or one or more crude drugs
11/16/2006	WO2005079752A8 Controlled release pharmaceutical compositions with improved bioavailability
11/16/2006	WO2005077968A8 17-methylene-or 17 - spiro - cyclopropane 7 - substituted estra - 1, 3, 5 (10) - triene derivatives with anti - estrogenic activity
11/16/2006	WO2005053648A8 Pre-metered dry powder inhaler for moisture-sensitive medicaments
11/16/2006	WO2004091614A8 Stabilized amlodipine maleate formations
11/16/2006	WO2002094236A9 Delivery of antipsychotics through an inhalation route
11/16/2006	US20060260010 Increased flower size, astaxanthin content, and/or reduced cardenolide content; astaxanthin-containing Adonis oleoresin and methods of extracting astaxanthin and other ketocarotenoids from flowers of Adonis palaestina plants, while reducing non-ketocarotenoids and cardenolides
11/16/2006	US20060260007 Inhibitors of yeast filamentous growth and method of their manufacture
11/16/2006	US20060258866 Carboxylic derivates
11/16/2006	US20060258861 Respiratory or gastrointestinal disorders; cancer
11/16/2006	US20060258860 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; for preventing, treating or delaying AIDS
11/16/2006	US20060258859 Histamine receptor antagonists; 4-[3-(4-Piperidin-1-yl-but-1-ynyl)-benzyl]-thiomorpholine; antiallergens, antihistamines, antiepileptic agents; asthma, alzheimer's disease, narcolepsy, motion sickness, attention deficit disorder, schizophrenia
11/16/2006	US20060258804 Hyperbranched dendron and methods of synthesis and use thereof
11/16/2006	US20060258755 Preparation of sevoflurane with negligible water content
11/16/2006	US20060258754 Method of treating endothelial dysfunction, oxidative stress and related diseases
11/16/2006	US20060258753 Such as 2-oxo-3-hydroxy-25-ethylidene-A-nor cholest-3-ene; for increasing synthesis of collagen
11/16/2006	US20060258752 Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitors
11/16/2006	US20060258751 A polyethylenimine block polymer with a N-substituted bis(acryloxyethyl)amine, conjugated with a nucleic acid or siRNA; improved drug delivery and bioavailability
11/16/2006	US20060258750 Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions
11/16/2006	US20060258749 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
11/16/2006	US20060258748 Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders
11/16/2006	US20060258746 Oral medicament for improvement in going to sleep or waking
11/16/2006	US20060258745 Deramciclane-fumarate tablets
11/16/2006	US20060258744 Medicament for preventing and/or treating peripheral neuropathies
11/16/2006	US20060258743 biosynthesis of ethoxylated decanoic acid by culturing Staphylococcus lentus in the ascites fluid that contains the Ehrlich tumor cell-derived material, extraction, separation; side effect reduction
11/16/2006	US20060258742 Hydroxy tetrahydro-naphthalenylurea derivatives
11/16/2006	US20060258741 C-(2-phenyl-cyclohexyl)-methylamine compounds for the treatment of anxiety disorders
11/16/2006	US20060258740 Diacylglycerol acyltransferase inhibitors
11/16/2006	US20060258739 Dihydrobenzofuran derivatives and uses therof
11/16/2006	US20060258738 Use of dronabinol for treatment of side effects of Hepatitis C therapy
11/16/2006	US20060258737 Resistance-repellent retroviral protease inhibitors
11/16/2006	US20060258736 Dosing regimen
11/16/2006	US20060258735 1,3-Bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
11/16/2006	US20060258734 Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of Levetiracetam and analogues
11/16/2006	US20060258733 Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives
11/16/2006	US20060258732 Treatment and prevention of gastrointestinal disease using antagonists or partial agonists of 5HT1a receptors
11/16/2006	US20060258731 Antitumor compound and therapeutic uses thereof
11/16/2006	US20060258730 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
11/16/2006	US20060258729 Antibacterial pyrazole carboxylic acid hydrazides
11/16/2006	US20060258728 Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
11/16/2006	US20060258727 Olmesartan medoxomil with reduced levels of impurities
11/16/2006	US20060258726 1,5-Disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases
11/16/2006	US20060258725 4-(Substituted phenoxy or anilino)-3-phenyl- or phenylalkylisoxazoles: 3-{[(4-{[3-(2,6-Dichlorophenyl)-5-isopropylisoxazol-4-yl]methoxy}-2-methylphenyl)-(methyl)amino]methyl}benzoic acid; cardiovascular disease, cholestatic liver disease, organ fibrosis, triglycerides, increasing high density lipoprotein
11/16/2006	US20060258724 Anticoagulants; cardiovascular disorders; atherosclerosis; antiarthritic agents; Alzheimer's disease; anticancer agents
11/16/2006	US20060258723 Substituted Heteroaryl- and Phenylsulfamoyl Compounds
11/16/2006	US20060258722 Condensed ring compound
11/16/2006	US20060258721 neuronal nitric oxide synthase (nNOS) isoform inhibitors; 2-ethyl-1-(1H-indol-5-yl)-isothiourea; neurogenerative disorders, stroke, reperfusion injury, head trauma, migraine headache, neuropathic pain, drug abuse, hyperalgesia
11/16/2006	US20060258720 1-Aroyl-2-heteroaryl- or heterocyclyl-4-alkyl-4-pyrrolidinylcarboxylic acids or esters (rel-(2S,4R,5R)-2-Isobutyl-1-(3-methoxy-4-tert-butylbenzoyl)-4-ethoxymethyl-5-(1,3-thiazol-2-yl)pyrrolidine-2-carboxylic acid); antiviral agents; hepatitus C
11/16/2006	US20060258719 Modulators of indoleamine 2,3-dioxygenase and methods of using the same
11/16/2006	US20060258718 Carbamic acid (R)-(+)-1-(2-chloro-phenyl)-2-tetrazol-2-yl-ethyl ester ; anticonvulsants; anxiety, depression, convulsion, epilepsy, migraine, bipolar disorder, drug abuse, smoking, ADHD, obesity, sleep disorder, neuropathic pain, stroke, cognitive impairment, neurodegeneration, stroke and muscle spasm
11/16/2006	US20060258717 Organic compounds
11/16/2006	US20060258716 Methods and compositions for the treatment of helicobacter pylori-associated diseases using endoperoxide bridge-containing compounds
11/16/2006	US20060258715 Therapeutic combinations for the treatment or prevention of depression
11/16/2006	US20060258714 N-{[8-(2-chlorophenyl)-3,4-dihydro-2H-chromen-2-yl]methyl}-N-methylamine hydrochloride; agonists or partial agonists of the 2C subtype of brain serotonin receptors; antidepressant, central nervous system disorders: schizophrenia, psychoses, Alzheimer's, Parkinson's disease; cognition activator, obesity
11/16/2006	US20060258713 Treatment of pain
11/16/2006	US20060258712 Methods for modulating bladder function
11/16/2006	US20060258711 Treatment of drug abuse
11/16/2006	US20060258710 Indolylalkylamino-methylidenecarbamate derivatives useful as gnrh antagonists
11/16/2006	US20060258709 Combination of a cb1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity
11/16/2006	US20060258708 Method for treating Parkinson's disease and other neurological diseases
11/16/2006	US20060258707 Benzimidazolidinone derivatives as muscarinic agents
11/16/2006	US20060258706 Solid forms of a JNK inhibitor
11/16/2006	US20060258705 Process for making crystalline donepezil hydrochloride monohydrate
11/16/2006	US20060258704 2-Oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders
11/16/2006	US20060258703 Remedy for pruritus comprising piperidine derivative as the active ingredient
11/16/2006	US20060258702 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258701 glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus; 3-(4-methoxy-phenylsulfanyl)-6-(4H-[1,2,4]triazol-3-yl-sulfanyl)-N-([1,3,4]thiadiazol-2-yl)-2-pyridine carboxamide
11/16/2006	US20060258700 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
11/16/2006	US20060258699 Compounds for inhibiting KSP kinesin activity
11/16/2006	US20060258698 Liquid formulations for treatment of diseases or conditions
11/16/2006	US20060258697 Method of augmenting the antitumor activity of anticancer agents
11/16/2006	US20060258696 Use of opioid antagonists to attenuate endothelial cell proliferation and migration
11/16/2006	US20060258695 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
11/16/2006	US20060258694 Anticancer agents; antiinflammatory agents; skin disorders; inflamamtory bowel disorders; vision defects; Alzheimer's disease
11/16/2006	US20060258693 Halogenated quinazolinyl nitrofurans as antibacterial agents
11/16/2006	US20060258692 Quinazolinone compositions for regulation of gene expression related to pathological processes
11/16/2006	US20060258691 Methods and compositions for improving cognition
11/16/2006	US20060258690 Spiro-substituted pyrrologyrimidines
11/16/2006	US20060258689 Fused heterocyclic compounds, and compositions and uses thereof
11/16/2006	US20060258688 Method of treating brain ischemia
11/16/2006	US20060258687 Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives
11/16/2006	US20060258686 Method of treatment of myocardial infarction
11/16/2006	US20060258685 Substituted pyrazolopyrimidines, methods for the production thereof, use of the same for controlling pathogenic fungi, and agents containing said compounds
11/16/2006	US20060258684 2-[2-[4-[(4-chlorophenyl) phenylmethyl]-1-piperazinyl]ethoxy]acetic acid monohydrochloride as anti-allergenic compound and process for its production
11/16/2006	US20060258683 Para-sulfonyl substituted phenyl compounds as modulators of ppars
11/16/2006	US20060258682 Benzofuran compounds
11/16/2006	US20060258681 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
11/16/2006	US20060258680 Chromenoneindoles
11/16/2006	US20060258679 Process of preparing ziprasidone mesylate
11/16/2006	US20060258678 Novel indole derivatives
11/16/2006	US20060258677 Novel crystalline forms of gatifloxacin and processes for preparation
11/16/2006	US20060258676 Novel crystalline forms of gatifloxacin and processes for preparation
11/16/2006	US20060258675 Novel crystalline forms of gatofloxacin and processes for preparation
11/16/2006	US20060258674 Novel crystalline forms of gatifloxacin and processes for preparation
11/16/2006	US20060258673 Process of making crystalline Type II aripiprazole

1 ... 4004 4005 4006 4007 4008 4009 4010 4011 4012 4013 4014 4015 4016 4017 4018 4019 4020 4021 4022 4023 4024 ... 7860